[1]SUNG H,FERLAY J,SIEGEL R L,et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA:a cancer journal for clinicians,2021,71(3):209-249.
[2]LI J,XU J,ZHENG Y,et al. Esophageal cancer:Epidemiology,risk factors and screening[J]. Chinese journal of cancer research,2021,33(5):535-547.
[3]KAKEJI Y,OSHIKIRI T,TAKIGUCHI G,et al. Multimodality approaches to control esophageal cancer:development of chemoradiotherapy,chemotherapy,and immunotherapy[J]. Esophagus,2021,18(1):25-32.
[4]YANG J,LIU X,CAO S,et al. Understanding esophageal cancer:the challenges and opportunities for the next decade[J]. Frontiers in oncology,2020,10(17):27-40.
[5]ZHENG Y,CHEN Z,HAN Y,et al. Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment[J]. Nature communications,2020,11(1):6268-6285.
[6]CHEN H,WU J,LU L,et al. Identification of hub genes associated with immune infiltration and predict prognosis in hepatocellular carcinoma via bioinformatics approaches[J]. Frontiers in genetics,2020,11(57):62-79.
[7]VAN IJZENDOORN D G P,SZUHAI K,BRIAIRE-DE BRUIJN I H,et al. Machine learning analysis of gene expression data reveals novel diagnostic and prognostic biomarkers and identifies therapeutic targets for soft tissue sarcomas[J]. PLoS computational biology,2019,15(2):6826-6845.
[8]LING B,LIAO X,HUANG Y,et al. Identification of prognostic markers of lung cancer through bioinformatics analysis and in vitro experiments[J]. International journal of oncology,2020,56(1):193-205.
[9]SZKLARCZYK D,GABLE A L,LYON D,et al. STRING v11:protein-protein association networks with increased coverage,supporting functional discovery in genome-wide experimental datasets[J]. Nucleic acids research,2019,47(D1):D607-D613.
[10]CHIN C H,CHEN S H,WU H H,et al. cytoHubba:identifying hub objects and sub-networks from complex interactome[J]. BMC systems biology,2014,8(Suppl 4):S11-S18.
[11]HANAHAN D,WEINBERG R A. Hallmarks of cancer:the next generation[J]. Cell,2011,144(5):646-674.
[12]JIANG N,DAI Q,SU X,et al. Role of PI3K/AKT pathway in cancer:the framework of malignant behavior[J]. Molecular biology reports,2020,47(6):4587-4629.
[13]BAO Y,WANG L,SHI L,et al. Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer[J]. Cellular & molecular biology letters,2019,24(6):38-58.
[14]RAPOPORT B L,STEEL H C,THERON A J,et al. Role of the neutrophil in the pathogenesis of advanced cancer and impaired responsiveness to therapy[J]. Molecules(Basel,Switzerland),2020,25(7):E1618-E1640.
[15]HA H,DEBNATH B,NEAMATI N. Role of the CXCL8-CXCR1/2 axis in cancer and inflammatory diseases[J]. Theranostics,2017,7(6):1543-1588.
[16]田倩,曹润怿,王方方,等. CXCL13 参与AR促进前列腺癌细胞体内异种移植瘤的生长[J]. 南京师大学报(自然科学版),2018,41(3):70-77.
[17]BILUSIC M,HEERY C R,COLLINS J M,et al. Phase I trial of HuMax-IL8(BMS-986253),an anti-IL-8 monoclonal antibody,in patients with metastatic or unresectable solid tumors[J]. Journal for immunotherapy of cancer,2019,7(1):240-248.
[18]LIN C,HE H,LIU H,et al. Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer[J]. Gut,2019,68(10):1764-1773.
[19]XIONG X,LIAO X,QIU S,et al. CXCL8 in tumor biology and its implications for clinical translation[J]. Frontiers in molecular biosciences,2022,9(7):846-859.
[20]LIN C H,CHENG H W,MA H P,et al. Thrombin induces NF-kappaB activation and IL-8/CXCL8 expression in lung epithelial cells by a Rac1-dependent PI3K/Akt pathway[J]. The journal of biological chemistry,2011,286(12):10483-10494.
[21]YANG L,LIU L,GAO H,et al. The stem cell factor SALL4 is an essential transcriptional regulator in mixed lineage leukemia-rearranged leukemogenesis[J]. Journal of hematology & oncology,2017,10(1):159-180.
[22]REIS S T,LEITE K R M,PIOVESAN L F,et al. Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer[J]. BMC urology,2012,12(11):18-23.
[23]INOUE K,SLATON J W,EVE B Y,et al. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer[J]. Clinical cancer research:an official journal of the american association for cancer research,2000,6(5):2104-2119.
[24]JIA X,LU M,RUI C,et al. Consensus-expressed CXCL8 and MMP9 identified by meta-analyzed perineural invasion gene signature in gastric cancer microarray data[J]. Frontiers in genetics,2019,10(7):851-858.
[25]JIANG C H,LIANG W H,LI F P,et al. Distribution and prognostic impact of M1 macrophage on esophageal squamous cell carcinoma[J]. Carcinogenesis,2021,42(4):537-545.
[26]MEHLA K,SINGH P K. Metabolic regulation of macrophage polarization in cancer[J]. Trends in cancer,2019,5(12):822-834.
[27]XU F,WEI Y,TANG Z,et al. Tumor-associated macrophages in lung cancer:Friend or foe?(Review)[J]. Molecular medicine reports,2020,22(5):4107-4115.
[28]CHEN S R,LUO Y P,ZHANG J K,et al. Study on immune function of dendritic cells in patients with esophageal carcinoma[J]. World journal of gastroenterology,2004,10(7):934-939.
[29]KOCIÁN P,EDIVCOVÁ M,DRGÁACˇ J,et al. Tumor-infiltrating lymphocytes and dendritic cells in human colorectal cancer:their relationship to KRAS mutational status and disease recurrence[J]. Human immunology,2011,72(11):1022-1028.
[30]宋政文,赵智辉. 靶向树突状细胞的结肠癌肿瘤疫苗的制备[J]. 南京师大学报(自然科学版),2020,43(3):112-119.
[31]DERAKHSHANI A,VAHIDIAN F,ALIHASANZADEH M,et al. Mast cells:A double-edged sword in cancer[J]. Immunology letters,2019,209(5):28-35.
[32]HAN L,JIA Y,SONG Q,et al. Prognostic significance of preoperative absolute peripheral monocyte count in esophageal squamous cell carcinoma[J]. Diseases of the esophagus:official journal of the international society for diseases of the esophagus,2016,29(7):740-746.
[33]SIMONI Y,BECHT E,FEHLINGS M,et al. Bystander CD8+T cells are abundant and phenotypically distinct in human tumour infiltrates[J]. Nature,2018,557(7706):575-579.